Heart Attack Survivors Enrolled in Study Not Told of Dangers
A federal investigation has revealed that heart attack survivors enrolled in a study using Chelation, which involves periodic infusions of the drug Disodium ETD, were not told enough about potential dangers from the drug, including death.
Findings from the investigation were revealed this week by the U.S. Office for Human Research Protections in a letter to the three medical centers leading the study, Mount Sinai Medical Center in Miami Beach, Florida; the University of Miami; and Duke University Medical Center in Durham, North Carolina.
The probe found that several doctors doing the study had been accused of poor practices by state medical boards or involved in insurance fruad, and that at least three are convicted felons. Federal officials recommended corrective steps to researchers, but have allowed to study to go on while the probe continues. This decision has angered critics. Arthur Caplan, Chief of Bioethics at the University of Pennsylvania stated, “This study should not be going on. It is incredibly unethical to subject anyone to these risks.”
Disodium ETD carries a risk of kidney failure, bone marrow problems, shock, low blood pressure, convulsions, heart rhythm problems, allergic reactions and breath troubles, reported the American Heart Association.
For additional information see: http://www.msnbc.msn.com/id/31715589/ns/health-heart_health/